Skip to main content
Figure 1 | Stem Cell Research & Therapy

Figure 1

From: Effects of bone marrow mononuclear cells from healthy or ovalbumin-induced lung inflammation donors on recipient allergic asthma mice

Figure 1

Flowchart and timeline of the study design. Control, mice sensitized and challenged with saline and treated with saline; OVA, mice sensitized and challenged with ovalbumin; OVA-SAL, mice sensitized and challenged with ovalbumin and treated with saline; OVA-BMMC-Control, mice sensitized and challenged with ovalbumin and treated with bone marrow mononuclear cells (BMMCs) obtained from control donors, 24 hours after last challenge (2 × 106 cells/mouse); OVA-BMMC-OVA, mice sensitized and challenged with ovalbumin and treated with BMMCs obtained from OVA donors, 24 hours after last challenge (2 × 106 cells/mouse). All data were analyzed on day 54.

Back to article page